Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death
about
Targeted Therapies for Brain Metastases from Breast CancerRadiotherapy of brain metastases from breast cancer: Treatment results and prognostic factors.Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival.Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases.Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives.The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases.Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions.Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis.Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer.Risk factors and survival outcomes in patients with brain metastases from breast cancer.A nomogram for predicting survival in patients with breast cancer brain metastasis.Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.
P2860
Q28068154-8C6D6061-47C4-4089-84EC-A808CF33FBE0Q30315204-1CC5030D-5918-4F37-B388-DE076D63540CQ33777436-E1126583-2B52-4CA8-A44E-4B5EDE490A8EQ35608531-A17461F7-59A6-47DC-8991-16195524B506Q36287951-5E01DC13-5222-4AF6-82A4-87BFD498C8A2Q37562651-E122DF57-6FDF-422D-AD51-F2756C68C040Q38209464-DC915356-D4C4-415F-A14A-0665147BD502Q38289478-95ECD08E-5C4A-449A-B448-05EF67BE1D31Q38575259-CD26956B-0761-421B-A98E-C7E5DAB71912Q39652258-6742DF2C-0BFA-4CDB-B629-EDD4859768F0Q41489396-2C269CA1-594C-4833-82D0-81075BFC57B9Q43453953-AE83BDDE-B546-4FA9-B149-1318D1005922Q50899949-690DA31D-5D98-469C-8BE8-09862BA70A39Q55024723-BAAC69BD-5FEF-435E-B507-3D5DE51D33AEQ55394663-54D40500-1CC0-4821-90B3-28FE11147976
P2860
Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Brain metastases from breast c ...... trastuzumab and cause of death
@ast
Brain metastases from breast c ...... trastuzumab and cause of death
@en
Brain metastases from breast c ...... trastuzumab and cause of death
@nl
type
label
Brain metastases from breast c ...... trastuzumab and cause of death
@ast
Brain metastases from breast c ...... trastuzumab and cause of death
@en
Brain metastases from breast c ...... trastuzumab and cause of death
@nl
prefLabel
Brain metastases from breast c ...... trastuzumab and cause of death
@ast
Brain metastases from breast c ...... trastuzumab and cause of death
@en
Brain metastases from breast c ...... trastuzumab and cause of death
@nl
P2093
P2860
P356
P1433
P1476
Brain metastases from breast c ...... trastuzumab and cause of death
@en
P2093
Alain Labib
Christophe Massard
Emmanuelle Mouret-Fourme
Julie Gachet
Ludivine Jouanneau
Maya Gutierrez
Pascal Cherel
Romuald Le Scodan
Youlia Kirova
P2860
P2888
P356
10.1186/1471-2407-11-395
P407
P577
2011-09-19T00:00:00Z
P5875
P6179
1018888262